| scholarly article | Q13442814 |
| P50 | author | Ralph A. DeFronzo | Q58689309 |
| P2093 | author name string | A Cervera | |
| S Ghosh | |||
| M Fernandez | |||
| C Triplitt | |||
| E Cersosimo | |||
| N Musi | |||
| S Reyna | |||
| J Joya-Galeana | |||
| P2860 | cites work | Cloning of adiponectin receptors that mediate antidiabetic metabolic effects | Q24304889 |
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group | Q29547282 | ||
| Effects of intensive glucose lowering in type 2 diabetes | Q29547736 | ||
| The pathogenesis of atherosclerosis: a perspective for the 1990s | Q29547827 | ||
| Glucose control and vascular complications in veterans with type 2 diabetes | Q29619213 | ||
| Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial | Q29619886 | ||
| Does carotid intima-media thickness regression predict reduction of cardiovascular events? A meta-analysis of 41 randomized trials | Q34153066 | ||
| Glucose clamp technique: a method for quantifying insulin secretion and resistance | Q34191986 | ||
| Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial | Q34572519 | ||
| Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials | Q34686089 | ||
| Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial | Q34766176 | ||
| Effects of insulin infusion on human skeletal muscle pyruvate dehydrogenase, phosphofructokinase, and glycogen synthase. Evidence for their role in oxidative and nonoxidative glucose metabolism | Q35578164 | ||
| Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus | Q37141727 | ||
| Hyperlipidaemia in diabetes | Q37786744 | ||
| Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force | Q39605814 | ||
| Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus | Q40102509 | ||
| AMP-activated protein kinase (AMPK) is activated in muscle of subjects with type 2 diabetes during exercise | Q43596055 | ||
| Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes | Q43666606 | ||
| Dose-response effect of elevated plasma free fatty acid on insulin signaling | Q46513253 | ||
| Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms | Q46972124 | ||
| Application of high-performance liquid chromatography of plasma fatty acids as their phenacyl esters to evaluate splanchnic and renal fatty acid balance in vivo. | Q51563024 | ||
| Effects of insulin on skeletal muscle glucose storage, oxidation, and glycolysis in humans | Q67301241 | ||
| Coated Charcoal Immunoassay of Insulin | Q71162157 | ||
| An inexpensive, rapid and precise affinity chromatography method for the measurement of glycosylated haemoglobins | Q71818075 | ||
| Transient triglyceridemia decreases vascular reactivity in young, healthy men without risk factors for coronary heart disease | Q73936824 | ||
| Influences of glucose loading and of injected insulin on hepatic glucose output | Q79273897 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 373-382 | |
| P577 | publication date | 2011-05-01 | |
| P1433 | published in | Diabetes - Metabolism: Research and Reviews | Q15750056 |
| P1476 | title | Effects of insulin and oral anti-diabetic agents on glucose metabolism, vascular dysfunction and skeletal muscle inflammation in type 2 diabetic subjects | |
| P478 | volume | 27 |
| Q47745734 | Adiponectin, Leptin, and Leptin Receptor in Obese Patients with Type 2 Diabetes Treated with Insulin Detemir |
| Q90448263 | Chronic dosing with metformin plus bosentan decreases in vitro pulmonary artery contraction from isolated arteries in adults with pulmonary hypertension |
| Q37106424 | Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE). |
| Q38085225 | Frailty and safety: the example of diabetes |
| Q36686775 | Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 diabetes: a preliminary report |
| Q35438220 | Liraglutide, a glucagon-like peptide-1 analog, increased insulin sensitivity assessed by hyperinsulinemic-euglycemic clamp examination in patients with uncontrolled type 2 diabetes mellitus. |
| Q36228769 | Obesity and pulmonary hypertension: a review of pathophysiologic mechanisms |
| Q64252546 | Optimization of Hyperglycemic Induction in Zebrafish and Evaluation of Its Blood Glucose Level and Metabolite Fingerprint Treated with Jack Leaf Extract |
| Q48451001 | Pre-treatment with metformin activates Nrf2 antioxidant pathways and inhibits inflammatory responses through induction of AMPK after transient global cerebral ischemia. |
| Q36673550 | The vascular endothelium in diabetes--a therapeutic target? |
| Q54858365 | Trends in the treatment of risk factors for stroke in a Czech stroke unit. |
| Q36477239 | Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. |
Search more.